Article and Video CATEGORIES
MET-Amplified Lung Cancer: A New Target for XALKORI?
Lung cancer patients with high MET amplification appear to do well on Xalkori (crizotinib), a drug that is approved for ALK positive patients.
[powerpress]
Please feel free to offer comments and raise questions in our
discussion forums.